concept
call
revers
genet
recent
enabl
research
st
jude
children
research
hospit
http
wwwstjudeorg
construct
experiment
vaccin
potenti
pandem
influenza
strain
less
month
similar
approach
could
use
develop
vaccin
sever
acut
respiratori
syndrom
sar
vaccin
new
strain
wellknown
virus
emerg
infecti
diseas
use
take
mani
month
develop
howev
increas
avail
genom
sequenc
pathogen
expedit
develop
safer
effect
vaccin
virologist
explain
richard
webbi
postdoctor
fellow
depart
infecti
diseas
st
jude
revers
genet
mean
product
viru
clone
dna
team
led
yoshihiro
kawaoka
professor
virolog
univers
wisconsinmadison
http
wwwvetmedwiscedu
first
achiev
feat
influenza
segment
negativesens
rna
viru
classic
method
make
vaccin
new
flu
variant
explain
webbi
coinfect
hen
egg
field
isol
vaccin
strain
genet
select
reassort
virus
contain
desir
mix
genom
fragment
process
take
mani
week
pathogen
tradit
reassort
never
option
webbi
continu
instead
develop
vaccin
st
jude
team
isol
genom
segment
encod
haemagglutinin
neuraminidaseth
surfac
glycoprotein
neutral
antibodi
rais
engin
haemagglutinin
less
pathogen
mix
plasmid
carri
two
fragment
six
plasmid
carri
remain
flu
genom
fragment
standard
vaccin
strain
fig
four
week
went
newli
isol
potenti
pandem
flu
strain
experiment
vaccin
say
webbi
flu
vaccin
first
produc
revers
genet
go
clinic
trial
speed
produc
comment
rino
rappuoli
vice
presid
vaccin
research
chiron
corpor
http
wwwchironcom
could
critic
turn
next
longoverdu
pandem
strain
emerg
far
east
revers
genet
use
develop
vaccin
mani
virus
includ
respiratori
syncyti
virus
parainfluenza
virus
updat
news
definit
technolog
broaden
includ
express
protein
engin
gene
futur
applic
virtual
boundless
even
year
ago
say
rappuoli
genet
use
minim
vaccin
develop
nowaday
would
even
tri
develop
vaccin
without
use
genet
tool
avail
speed
one
aspect
revolut
even
import
flexibl
avail
vaccin
design
exampl
say
kawaoka
mani
compani
plan
use
revers
genet
produc
attenu
flu
strain
use
live
vaccin
give
protect
current
inactiv
vaccin
case
say
rappuoli
technolog
facilit
develop
previous
elus
vaccin
exampl
year
fail
develop
effect
vaccin
meningococcu
b
revers
genet
went
get
genom
sequenc
identifi
new
antigen
start
clinic
vaccin
trial
less
four
year
earliest
known
case
sar
report
mid
novemb
may
probabl
case
death
occur
countri
respons
threat
global
health
research
move
fast
earli
march
noon
knew
diseas
caus
explain
rappuoli
late
march
somebodi
suggest
could
coronaviru
mid
april
knew
genet
code
chiron
alreadi
express
sar
envelop
protein
tri
develop
vaccin
continu
also
use
inform
avail
anim
coronaviru
introduc
attenu
mutat
sar
viru
make
live
vaccin
latter
approach
recombin
viru
gener
easi
task
given
size
coronaviru
rna
genom
say
lui
enjuan
research
professor
centro
nacion
de
biotecnologia
http
wwwcnbuam
sinc
system
avail
sever
laboratori
engin
coronaviru
genom
vector
vaccin
develop
gene
therapi
say
enjuan
possibl
make
vaccin
sar
adapt
avail
infecti
cdna
clone
howev
enjuan
warn
vaccin
futur
type
vaccin
base
singl
viral
compon
exampl
made
quickli
say
expert
agre
use
revers
genet
make
recombin
sar
vaccin
could
ultim
effect
adapt
system
vaccin
develop
requir
consider
research
setup
time
emphasi
use
inactiv
sar
viru
vaccin
approach
us
nation
institut
allergi
infecti
diseas
http
wwwniaidnihgov
initi
focu
although
niaid
director
anthoni
fauci
say
approach
soon
knowledg
caus
sar
etiolog
becom
avail
classic
approach
fast
fauci
estim
least
year
vaccin
readi
human
test
probabl
fastest
way
go
conclud
kawaoka
